Entropy Technologies, LP Rocket Pharmaceuticals, Inc. Transaction History
Entropy Technologies, LP
- $938 Billion
- Q1 2024
A detailed history of Entropy Technologies, LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Entropy Technologies, LP holds 13,544 shares of RCKT stock, worth $279,683. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,544
Previous 17,344
21.91%
Holding current value
$279,683
Previous $520 Million
29.8%
% of portfolio
0.04%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding RCKT
# of Institutions
204Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$365 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$189 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$111 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$86.6 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.56B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...